Stockscreener 앱 받기
91.00
2.62%
2.32
시간 외 거래:
91.39
0.39
+0.43%
전일 마감가:
$88.68
열려 있는:
$89.34
하루 거래량:
7.40M
Relative Volume:
1.53
시가총액:
$282.23B
수익:
$58.07B
순이익/손실:
$9.40B
주가수익비율:
30.22
EPS:
3.0113
순현금흐름:
$8.49B
1주 성능:
+2.13%
1개월 성능:
+9.35%
6개월 성능:
+30.60%
1년 성능:
+41.61%
1일 변동 폭
$89.34
$91.91
1주일 범위
$88.41
$91.91
52주 변동 폭
$61.24
$91.91
아스트라제네카 ADR Stock (AZN) Company Profile
명칭
Astrazeneca PLC
전화
44 20 3749 5000
주소
1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge
AZN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AZN
Astrazeneca PLC
|
91.00 | 274.96B | 58.07B | 9.40B | 8.49B | 3.0113 |
아스트라제네카 ADR Stock (AZN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-27 | 재개 | Jefferies | Buy |
| 2025-10-16 | 다운그레이드 | Deutsche Bank | Hold → Sell |
| 2025-04-15 | 개시 | Exane BNP Paribas | Outperform |
| 2025-02-13 | 업그레이드 | UBS | Neutral → Buy |
| 2025-02-12 | 개시 | Morgan Stanley | Overweight |
| 2024-11-20 | 업그레이드 | UBS | Sell → Neutral |
| 2024-11-06 | 업그레이드 | Deutsche Bank | Sell → Hold |
| 2024-09-13 | 다운그레이드 | Deutsche Bank | Hold → Sell |
| 2024-05-30 | 개시 | Goldman | Buy |
| 2024-04-16 | 업그레이드 | Deutsche Bank | Sell → Hold |
| 2024-02-08 | 다운그레이드 | Deutsche Bank | Hold → Sell |
| 2024-01-23 | 개시 | Morgan Stanley | Overweight |
| 2024-01-16 | 재개 | UBS | Sell |
| 2024-01-03 | 다운그레이드 | Jefferies | Buy → Hold |
| 2023-12-18 | 개시 | HSBC Securities | Buy |
| 2023-09-25 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-07-14 | 개시 | HSBC Securities | Buy |
| 2023-07-12 | 업그레이드 | UBS | Neutral → Buy |
| 2023-07-05 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2023-04-11 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2023-01-05 | 개시 | BMO Capital Markets | Outperform |
| 2022-09-15 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2022-09-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-29 | 업그레이드 | Argus | Hold → Buy |
| 2022-06-14 | 다운그레이드 | UBS | Buy → Neutral |
| 2022-02-11 | 업그레이드 | DZ Bank | Sell → Hold |
| 2021-12-07 | 다운그레이드 | Jefferies | Buy → Hold |
| 2021-08-12 | 재개 | JP Morgan | Overweight |
| 2021-04-12 | 다운그레이드 | Argus | Buy → Hold |
| 2021-03-16 | 업그레이드 | Jefferies | Hold → Buy |
| 2021-02-25 | 업그레이드 | UBS | Neutral → Buy |
| 2021-01-15 | 개시 | Deutsche Bank | Buy |
| 2020-12-07 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-11-30 | 업그레이드 | UBS | Sell → Neutral |
| 2020-11-11 | 업그레이드 | HSBC Securities | Reduce → Hold |
| 2020-09-29 | 개시 | Berenberg | Buy |
| 2019-11-22 | 개시 | SVB Leerink | Outperform |
| 2019-10-25 | 업그레이드 | Liberum | Hold → Buy |
| 2019-04-02 | 다운그레이드 | UBS | Neutral → Sell |
| 2019-02-05 | 개시 | Exane BNP Paribas | Outperform |
| 2019-01-25 | 업그레이드 | Shore Capital | Hold → Buy |
| 2018-12-11 | 재개 | Jefferies | Hold |
| 2018-10-09 | 개시 | Guggenheim | Buy |
| 2018-08-16 | 다운그레이드 | Jefferies | Buy → Hold |
| 2018-03-19 | 업그레이드 | Jefferies | Hold → Buy |
| 2018-02-06 | 재확인 | Leerink Partners | Mkt Perform |
| 2018-02-05 | 재확인 | Bernstein | Outperform |
| 2018-01-18 | 재확인 | Leerink Partners | Mkt Perform |
| 2017-12-29 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2017-10-16 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2017-09-25 | 업그레이드 | Exane BNP Paribas | Neutral → Outperform |
| 2017-09-22 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
모두보기
아스트라제네카 ADR 주식(AZN)의 최신 뉴스
AstraZeneca strengthens its manufacturing footprint in the US with a $2bn investment - MarketScreener
Why AstraZeneca Stock Bumped Higher Today - Yahoo Finance
AstraZeneca unveils USD2 billion manufacturing investment in Maryland - MarketScreener
AstraZeneca (AZN) to Invest $2B in U.S. Production Expansion - GuruFocus
AstraZeneca expands U.S. production footprint with $2B investment in Maryland - MSN
AstraZeneca to Invest $2 Billion to Expand Maryland Manufacturing Footprint - MarketScreener
AstraZeneca (AZN) Plans $2 Billion Expansion in Maryland - GuruFocus
AstraZeneca announces $2B investment in Maryland (AZN:NASDAQ) - Seeking Alpha
AstraZeneca to invest $2B in Maryland facilities - breakingthenews.net
AstraZeneca to invest $2 billion expanding Maryland manufacturing sites By Investing.com - Investing.com UK
AstraZeneca Plans $2 Billion Manufacturing Investment in Maryland, Supporting 2,600 Jobs and Catalyzing Economic Growth - MarketScreener
AstraZeneca to invest $2 billion as part of US manufacturing push - MarketScreener
AstraZeneca Plans $2 Bln Manufacturing Investment In Maryland - TradingView
AstraZeneca to invest $2B in Maryland manufacturing expansion, creating 300 jobs - The Business Journals
AZN Wins FDA Nod for Expanded Use of Rare Disease Drug, Koselugo - Finviz
What's Driving the Market Sentiment Around AstraZeneca PLC? - Benzinga
Will AstraZeneca PLC Depositary Receipt continue its uptrend2025 Volatility Report & Weekly High Momentum Picks - newser.com
Can AstraZeneca PLC (Common Stock) (ZEGA) stock surprise with quarterly resultsIPO Watch & Daily Profit Maximizing Tips - newser.com
What drives AstraZeneca PLC ZEG stock priceSwing Trading Ideas & Exceptional Growth Portfolio - earlytimes.in
AstraZeneca (AZN) Partners in $120M Pharmaceutical Training Init - GuruFocus
AstraZeneca's Alexion gets FDA approval for Koselugo (AZN:NASDAQ) - Seeking Alpha
AstraZeneca receives US FDA approval for Koselugo in adults with NF1 - Investing.com
[6-K] ASTRAZENECA PLC Current Report (Foreign Issuer) | AZN SEC FilingForm 6-K - Stock Titan
AstraZeneca PLCKoselugo (selumetinib) approved in the US - Research Tree
What insider trading reveals about AstraZeneca PLC Depositary Receipt stockWatch List & Trade Opportunity Analysis Reports - newser.com
Will AstraZeneca PLC (Common Stock) (ZEGA) stock deliver compounding returnsExit Point & Daily Stock Trend Reports - newser.com
AstraZeneca receives FDA approval for expanded Koselugo usage - Sharecast.com
AstraZeneca says Koselugo (Selumetinib) approved in the US - MarketScreener
AstraZeneca Unit's Neurofibromatosis Treatment Receives US Approval - MarketScreener
How AstraZeneca PLC (ZEG) stock valuation compares with sector2025 Top Decliners & Safe Capital Growth Trade Ideas - newser.com
Burning Rock Reports Third Quarter 2025 Financial Results - GlobeNewswire Inc.
Is AstraZeneca PLC (ZEG) stock positioned for digital growth era - newser.com
Is Precidian ETFs Trust AstraZeneca PLC stock safe for risk averse investorsWeekly Trend Summary & Target Return Focused Picks - newser.com
Can Precidian ETFs Trust AstraZeneca PLC stock deliver double digit returnsMarket Sentiment Review & Long-Term Capital Growth Strategies - newser.com
AstraZeneca PLC Depositary Receipt stock chart pattern explainedTrade Risk Assessment & Fast Moving Stock Trade Plans - newser.com
How AstraZeneca PLC (Common Stock) (ZEGA) stock compares with top peers2025 Technical Patterns & Safe Capital Growth Trade Ideas - newser.com
Why AstraZeneca PLC (Common Stock) (ZEGA) stock is favored by hedge funds2025 Trading Recap & Fast Exit and Entry Strategy Plans - newser.com
What valuation multiples suggest for AstraZeneca PLC Depositary Receipt stock2025 Volume Leaders & Expert Curated Trade Ideas - newser.com
Is Precidian ETFs Trust AstraZeneca PLC stock a top dividend aristocrat candidate2025 Top Decliners & Step-by-Step Swing Trade Plans - newser.com
Using fundamentals and technicals on AstraZeneca PLC Depositary ReceiptEarnings Summary Report & Weekly Stock Performance Updates - newser.com
AstraZeneca Wins FDA Approval for Selumetinib in Adult NF1 Patients - MarketScreener
AstraZeneca (AZN) Gains FDA Approval for Koselugo in Neurofibrom - GuruFocus
AstraZeneca (AZN) Gains FDA Approval for Koselugo in Adult Treat - GuruFocus
AstraZeneca trades near highs after robust financials drive institutional flows - Traders Union
Will Precidian ETFs Trust AstraZeneca PLC stock deliver compounding returnsJuly 2025 Macro Moves & Weekly High Return Opportunities - newser.com
Can AstraZeneca PLC Depositary Receipt stock sustain revenue growth2025 Top Decliners & Reliable Price Breakout Alerts - newser.com
Will AstraZeneca PLC Depositary Receipt stock benefit from sector rotationPortfolio Update Report & Weekly Setup with High ROI Potential - newser.com
Is AstraZeneca PLC (ZEG) stock undervalued historicallyWeekly Profit Report & Community Driven Trade Alerts - newser.com
Published on: 2025-11-18 17:18:56 - newser.com
What market sentiment indicators show for Precidian ETFs Trust AstraZeneca PLC stock2025 AllTime Highs & Low Risk Growth Stock Ideas - newser.com
아스트라제네카 ADR (AZN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):